Virulence of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa In Vitro and In Vivo

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 5, 2004, Pages 1876-1878

  Aoki, S ^a   Hirakata, Y ^a,c   Kondoh, A ^a   Gotoh, N ^b   Yanagihara, K ^a   Miyazaki, Y ^a   Tomono, K ^a   Yamada, Y ^a   Kohno, S ^a   Kamihira, S ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFPIROME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; SODIUM CHLORIDE; SULPERAZON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BLA IMP GENE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; GRAM NEGATIVE INFECTION; IN VITRO STUDY; IN VIVO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SURVIVAL RATE;

ANIMALS; BACTEREMIA; BETA-LACTAMASES; CEFTAZIDIME; CEPHALOSPORINS; CILASTATIN; CIPROFLOXACIN; DRUG THERAPY, COMBINATION; IMIPENEM; LEUKOPENIA; MALE; MICE; MICE, INBRED BALB C; PROTEASE INHIBITORS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STEM CELLS; THIENAMYCINS;

EID: 11144358257     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.5.1876-1878.2004     Document Type: Article

References (12)

1. IMP-7. Antimicrob. Agents Chemother. 46:255-258.
2. Hirakata, Y., B. B. Finlay, D. A. Simpson, S. Kohno, S. Kamihira, and D. P. Speert. 2000. Penetration of clinical isolate of Pseudomonas aeruginosa through MDCK epithelial cell monolayers. J. Infect. Dis. 187:765-769.
3. IMP. Antimicrob. Agents Chemother. 42:2006-2011.
4. Hirakata, Y., M. Kaku, K. Tomono, K. Tateda, N. Furuya, T. Mastumoto, R. Araki, and K. Yamaguchi. 1992. Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice. Antimicrob. Agents Chemother. 36:1198-1203.
5. Hirakata, Y., R. Srikumar, K. Poole, N. Gotoh, T. Suematsu, S. Kohno, S. Kamihira, R. E. W. Hancock, and D. P. Speert. 2002. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J. Exp. Med. 196:109-118.
6. Hirakata, Y., T. Yamaguchi, M. Nakano, K. Izumikawa, M. Mine, S. Aoki, A. Kondoh, J. Matsuda, M. Hirayama, K. Yanagihara, Y. Miyazaki, K. Tomono, Y. Yamada, S. Kamihira, and S. Kohno. 2003. Clinical and bacteriological characteristics of IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa. Clin. Infect. Dis. 37:26-32.
7. Iyobe, S., M. Tsunoda, and S. Mitsuhashi. 1994. Cloning and expression in Enterobacteriaceae of the extended-spectrum β-lactamase gene from a Pseudomonas aeruginosa plasmid. FEMS Microbiol. Lett. 121:175-180.
8. Iyobe, S., H. Yamada, S. Minami. 1996. Insertion of a carbapenemase gene cassette into an integron of a Pseudomonas aeruginosa plasmid. J. Antimicrob. Chemother. 38:1114-1115.
9. Matsuda, K., and M. Inoue. 2000. Evaluation of antibiotics by the method of initial bactericidal activity. Jpn. J. Antibiot. 53:667-671.
10. National Committee for Clinical Laboratory Standards. 2001. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. Scott, E. B., and D. C. Morrison. 1995. Difference in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis. J. Infect. Dis. 172:1519-1527.
12. Senda, K., Y. Arakawa, K. Nakashima, H. Ito, S. Ichiyama, K. Shimokata, N. Kato, and M. Ohta. 1996. Multifocal outbreaks of metallo-β -lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrob. Agents Chemother. 40:349-353.